3
|
Cieslik W, Szczepaniak J, Krasowska A, Musiol R. Antifungal Styryloquinolines as Candida albicans Efflux Pump Inhibitors: Styryloquinolines are ABC Transporter Inhibitors. Molecules 2020; 25:molecules25020345. [PMID: 31952124 PMCID: PMC7024281 DOI: 10.3390/molecules25020345] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2019] [Revised: 01/09/2020] [Accepted: 01/11/2020] [Indexed: 12/21/2022] Open
Abstract
Styrylquinolines are heterocyclic compounds that are known for their antifungal and antimicrobial activity. Metal complexation through hydroxyl groups has been claimed to be a plausible mechanism of action for these types of compounds. A series of novel structures with protected hydroxyl groups have been designed and synthesized to verify the literature data. Their antifungal activity against wild-type Candida albicans strain and mutants with silenced efflux pumps activity has been determined. Combinations with fluconazole revealed synergistic interactions that were dependent on the substitution pattern. These results open a new route for designing active antifungal agents on a styrylquinoline scaffold.
Collapse
Affiliation(s)
- Wioleta Cieslik
- Institute of Chemistry, University of Silesia, 75. Pułku Piechoty 1, 41-500 Chorzów, Poland;
| | - Joanna Szczepaniak
- Department of Biotransformation, Faculty of Biotechnology, University of Wroclaw, Joliot-Curie 14a, 50-383 Wroclaw, Poland; (J.S.); (A.K.)
| | - Anna Krasowska
- Department of Biotransformation, Faculty of Biotechnology, University of Wroclaw, Joliot-Curie 14a, 50-383 Wroclaw, Poland; (J.S.); (A.K.)
| | - Robert Musiol
- Institute of Chemistry, University of Silesia, 75. Pułku Piechoty 1, 41-500 Chorzów, Poland;
- Correspondence: ; Tel.: +48‐32‐3497726; Fax: +48‐32‐259‐99‐78
| |
Collapse
|
4
|
Senerovic L, Opsenica D, Moric I, Aleksic I, Spasić M, Vasiljevic B. Quinolines and Quinolones as Antibacterial, Antifungal, Anti-virulence, Antiviral and Anti-parasitic Agents. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2019; 1282:37-69. [PMID: 31515709 DOI: 10.1007/5584_2019_428] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Infective diseases have become health threat of a global proportion due to appearance and spread of microorganisms resistant to majority of therapeutics currently used for their treatment. Therefore, there is a constant need for development of new antimicrobial agents, as well as novel therapeutic strategies. Quinolines and quinolones, isolated from plants, animals, and microorganisms, have demonstrated numerous biological activities such as antimicrobial, insecticidal, anti-inflammatory, antiplatelet, and antitumor. For more than two centuries quinoline/quinolone moiety has been used as a scaffold for drug development and even today it represents an inexhaustible inspiration for design and development of novel semi-synthetic or synthetic agents exhibiting broad spectrum of bioactivities. The structural diversity of synthetized compounds provides high and selective activity attained through different mechanisms of action, as well as low toxicity on human cells. This review describes quinoline and quinolone derivatives with antibacterial, antifungal, anti-virulent, antiviral, and anti-parasitic activities with the focus on the last 10 years literature.
Collapse
Affiliation(s)
- Lidija Senerovic
- Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
| | - Dejan Opsenica
- Institute of Chemistry, Technology and Metallurgy, University of Belgrade, Belgrade, Serbia
- Center of excellence in Environmental Chemistry and Engineering, ICTM - University of Belgrade, Belgrade, Serbia
| | - Ivana Moric
- Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia
| | - Ivana Aleksic
- Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia
| | - Marta Spasić
- Faculty of Chemistry, University of Belgrade, Belgrade, Serbia
| | - Branka Vasiljevic
- Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia
| |
Collapse
|
5
|
Szczepaniak J, Cieślik W, Romanowicz A, Musioł R, Krasowska A. Blocking and dislocation of Candida albicans Cdr1p transporter by styrylquinolines. Int J Antimicrob Agents 2017; 50:171-176. [PMID: 28602766 DOI: 10.1016/j.ijantimicag.2017.01.044] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2016] [Revised: 01/20/2017] [Accepted: 01/30/2017] [Indexed: 01/10/2023]
Abstract
Styrylquinolines are a novel group of quinoline drugs that are known to have p53-independent antiproliferative activity and antiviral properties. This study evaluated the antifungal activity of these drugs more deeply, particularly their activity modulation towards Cdr1p, the main multidrug transporter of Candida albicans. Styrylquinolines were found to have antifungal activity and to work synergistically with fluconazole. Additionally, they decreased the extracellular concentration of rhodamine 6G in ABC-transporter-expressing cells. The cellular localization of GFP-tagged Cdr1p was assessed by epifluorescent microscopy. Styrylquinolines induce expression of Cdr1p, as confirmed by Western blotting. Three of four drugs tested caused the partial delocalization of transport protein to the cytoplasm. These results show the first evidence that styrylquinolines decrease the activity of ABC multidrug transporters in C. albicans.
Collapse
Affiliation(s)
| | - Wioleta Cieślik
- Institute of Chemistry, University of Silesia, Katowice, Poland
| | - Anna Romanowicz
- Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland
| | - Robert Musioł
- Institute of Chemistry, University of Silesia, Katowice, Poland
| | - Anna Krasowska
- Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland
| |
Collapse
|
6
|
Bardiot D, Thevissen K, De Brucker K, Peeters A, Cos P, Taborda CP, McNaughton M, Maes L, Chaltin P, Cammue BPA, Marchand A. 2-(2-Oxo-morpholin-3-yl)-acetamide Derivatives as Broad-Spectrum Antifungal Agents. J Med Chem 2015; 58:1502-12. [DOI: 10.1021/jm501814x] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Dorothée Bardiot
- Cistim Leuven vzw, Bioincubator
2, Gaston Geenslaan 2, 3001 Leuven, Belgium
| | - Karin Thevissen
- Centre
of Microbial and Plant Genetics, CMPG, KU Leuven, Kasteelpark Arenberg
20, Box 2460, 3001 Heverlee, Belgium
| | - Katrijn De Brucker
- Centre
of Microbial and Plant Genetics, CMPG, KU Leuven, Kasteelpark Arenberg
20, Box 2460, 3001 Heverlee, Belgium
| | - Annelies Peeters
- Centre
of Microbial and Plant Genetics, CMPG, KU Leuven, Kasteelpark Arenberg
20, Box 2460, 3001 Heverlee, Belgium
| | - Paul Cos
- Laboratory
of Microbiology, Parasitology and Hygiene (LMPH), Universiteit Antwerpen, Campus Drie Eiken, building S, Universiteitsplein 1, 2610 Antwerp, Belgium
| | - Carlos P. Taborda
- Instituto
de Ciencias Biomedicas, Departamento de Microbiologia, Universidade de Sao Paulo, Sao Paulo, SP 05508-900, Brazil
| | - Michael McNaughton
- Cistim Leuven vzw, Bioincubator
2, Gaston Geenslaan 2, 3001 Leuven, Belgium
| | - Louis Maes
- Laboratory
of Microbiology, Parasitology and Hygiene (LMPH), Universiteit Antwerpen, Campus Drie Eiken, building S, Universiteitsplein 1, 2610 Antwerp, Belgium
| | - Patrick Chaltin
- Cistim Leuven vzw, Bioincubator
2, Gaston Geenslaan 2, 3001 Leuven, Belgium
- Centre for Drug Design and Discovery, Bioincubator 2, Gaston Geenslaan 2, 3001 Leuven, Belgium
| | - Bruno P. A. Cammue
- Centre
of Microbial and Plant Genetics, CMPG, KU Leuven, Kasteelpark Arenberg
20, Box 2460, 3001 Heverlee, Belgium
- Department
of Plant Systems Biology, VIB, Technologiepark 927, 9052, Ghent, Belgium
| | - Arnaud Marchand
- Cistim Leuven vzw, Bioincubator
2, Gaston Geenslaan 2, 3001 Leuven, Belgium
| |
Collapse
|
7
|
Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms. Future Med Chem 2014; 6:77-90. [DOI: 10.4155/fmc.13.189] [Citation(s) in RCA: 114] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Invasive fungal infections are associated with very high mortality rates ranging from 20–90% for opportunistic fungal pathogens such as Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. Fungal resistance to antimycotic treatment can be genotypic (due to resistant strains) as well as phenotypic (due to more resistant fungal lifestyles, such as biofilms). With regard to the latter, biofilms are considered to be critical in the development of invasive fungal infections. However, there are only very few antimycotics, such as miconazole (azoles), echinocandins and liposomal formulations of amphotericin B (polyenes), which are also effective against fungal biofilms. Interestingly, these antimycotics all induce reactive oxygen species (ROS) in fungal (biofilm) cells. This review provides an overview of the different classes of antimycotics and novel antifungal compounds that induce ROS in fungal planktonic and biofilm cells. Moreover, different strategies to further enhance the antibiofilm activity of such ROS-inducing antimycotics will be discussed.
Collapse
|